Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial

Administrative Office of U.S. Courts, 1994, vol. 10 Alho, 2007, Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users, Drug Alcohol Depend., 88, 75, 10.1016/j.drugalcdep.2006.09.012 Amass, 2000, Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet, Drug Alcohol Depend., 58, 143, 10.1016/S0376-8716(99)00074-5 Amon, 2008, Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994–2004, Clin. Infect. Dis., 46, 1852, 10.1086/588297 Anglin, 1998, Drug use and crime: a historical review of research conducted by the UCLA Drug Abuse Research Center, Substance Use Misuse, 33, 1871, 10.3109/10826089809059325 Beyrer, 2007, HIV epidemiology update and transmission factors: risks and risk contexts–16th International AIDS Conference epidemiology plenary, Clin. Infect. Dis., 44, 981, 10.1086/512371 Binswanger, 2007, Release from prison-a high risk of death for former inmates, N. Engl. J. Med., 356, 157, 10.1056/NEJMsa064115 Bird, 2003, Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996–99, Addiction, 98, 185, 10.1046/j.1360-0443.2003.00264.x Blansfield, 1996, Inadequate treatment of opioid dependence due to society's attitudes and beliefs, Conn. Med., 60, 423 Butler, 2007, The 2004 Australian prison entrants’ blood-borne virus and risk behaviour survey, Aust N Z J Public Health, 31, 44, 10.1111/j.1753-6405.2007.00009.x Catania, H., 2003. Public health needed in prisons. Harm Reduction News: Newsletter of the International Harm Reduction Development Program of the Open Society Institute 4, 11, 13. Center for Substance Abuse Treatment, 2004 Chow, 2007 Dolan, 2003, A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system, Drug Alcohol Depend., 72, 59, 10.1016/S0376-8716(03)00187-X Eissenberg, 1997, Controlled opioid withdrawal evaluation during 72 dose omission in buprenorphine-maintained patients, Drug Alcohol Depend., 45, 81, 10.1016/S0376-8716(97)01347-1 Fiscella, 2004, Jail management of arrestees/inmates enrolled in community methadone maintenance programs, J. Urban Health: Bull. N. Y. Acad. Med., 81, 645, 10.1093/jurban/jth147 Food and Drug Administration www.fda.gov/cder/ob. FDA Orange Book, accessed April 14, 2008. Freudenberg, 2001, Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health, J. Urban Health, 78, 214, 10.1093/jurban/78.2.214 Fudala, 1998, Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts, Drug Alcohol Depend., 50, 1, 10.1016/S0376-8716(98)00008-8 Garcia, 2007, Buprenorphine-naloxone treatment for pre-release opioid-dependent inmates in Puerto Rico, J. Addict. Med., 1, 126, 10.1097/ADM.0b013e31814b8880 Goldsmith, 1984 Haig, 2003, Randomized controlled trial proves effectiveness of methadone maintenance treatment in prison, Can. HIV AIDS Policy Law Rev., 8, 48 Hall, 1993, Methadone maintenance treatment in patient: the New South Wales experience, Drug Alcohol Rev., 12, 193, 10.1080/09595239300185631 Hunt, 1985, It takes your heart: the image of methadone maintenance in the addict world and its effect on recruitment into treatment, Int. J. Addict., 20, 1751, 10.3109/10826088509047261 Jasinki, 1978, Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction, Arch. Gen. Psychiatry, 35, 501, 10.1001/archpsyc.1978.01770280111012 Johnson, 2000, A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence, N. Engl. J. Med., 343, 1290, 10.1056/NEJM200011023431802 Kang, 1997, Counselor attitudes in methadone maintenance, J. Maintenance Addict., 1, 41, 10.1300/J126v01n02_04 Kinlock, 2007, A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release, Drug Alcohol Depend., 91, 220, 10.1016/j.drugalcdep.2007.05.022 Langendam, 1998, Differentiation in the Amsterdam methadone dispensing circuit: determinants of methadone dosage and site of methadone prescription, Addiction, 93, 61, 10.1046/j.1360-0443.1998.931617.x Lewis, 1985, Buprenorphine, Drug Alcohol Depend., 14, 363, 10.1016/0376-8716(85)90067-5 Magura, 2007, Outcomes of buprenorphine maintenance in office-based practice, J. Addict. Dis., 26, 13, 10.1300/J069v26n02_03 Magura, 1993, The effectiveness of in-jail methadone maintenance, J. Drug Issues, 23, 75, 10.1177/002204269302300106 McBride, 1993, The drugs-crime relationship: an analytic framework, Prison J., 73, 257, 10.1177/0032855593073003002 McLellan, 1992, The fifth edition of the addiction severity index, J. Subst. Abuse. Treat., 9, 199, 10.1016/0740-5472(92)90062-S McMillan, 2005, Staff perspectives on methadone maintenance therapy MMT in a large southwestern jail, Addict. Res. Theory, 13, 53, 10.1080/16066350512331328159 Michel, 2005, Guidelines for substitution treatments in prison populations [Article in French], Encephale, 31, 92, 10.1016/S0013-7006(05)82377-2 Michels, 2007, Substitution treatment for opioid addicts in Germany, Harm Reduct J., 4, 5, 10.1186/1477-7517-4-5 National Association of State Alcohol and Drug Abuse Directors, Inc., 2006 National Institute of Justice, 2004 National Institute on Drug Abuse, 1999 Perez de los Cobos, 2004, A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain, Drug Alcohol Depend., 73, 307, 10.1016/j.drugalcdep.2003.11.001 Rance, 1978, The influence of drug-receptor kinetics on the pharmacological and pharmaco-kinetic profiles of buprenorphine Reynaud-Maurupt, 2005, High-dose buprenorphine substitution during incarceration, Presse Med., 34, 487, 10.1016/S0755-4982(05)83955-7 Rosenblum, 1991, Ambivalence toward methadone treatment among intravenous drug users, J. Psychoactive Drugs, 23, 21, 10.1080/02791072.1991.10472571 Simpson, 1998, Health, addiction treatment, and the criminal justice system Stallwitz, 2007, The impact of substitution treatment in prisons—a literature review, Int. J. Drug Policy, 186, 464, 10.1016/j.drugpo.2006.11.015 Tomasino, 2001, The Key Extended Entry Program KEEP: a methadone treatment program for opiate-dependent inmates, Mt. Sinai J. Med., 68, 14 Walsh, 1995, Acute administration of buprenorphine in humans: partial agonist and blockade effects, J. Pharmacol. Exp. Ther., 274, 361 Walsh, 1994, Clinical pharmacology buprenorphine: ceiling affects at high dose, Clin. Pharmacol. Ther., 55, 569, 10.1038/clpt.1994.71 Westermeyer, 2000, Addiction, community and state: a review, Am. J. Addict., 91, 79, 10.1080/10550490050172254 White, 2000, Dynamics of the drug-crime relationship, 151 Zule, 1998, Attitudes toward methadone maintenance: implications for HIV prevention, J. Psychoactive Drugs, 301, 89, 10.1080/02791072.1998.10399674